A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,235,900 shares of CDNA stock, worth $28.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,235,900
Previous 1,512,700 18.3%
Holding current value
$28.6 Million
Previous $23.5 Million 64.24%
% of portfolio
0.06%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$14.41 - $33.99 $3.99 Million - $9.41 Million
-276,800 Reduced 18.3%
1,235,900 $38.6 Million
Q2 2024

Aug 09, 2024

BUY
$7.56 - $16.15 $666,036 - $1.42 Million
88,100 Added 6.18%
1,512,700 $23.5 Million
Q1 2024

May 13, 2024

BUY
$7.96 - $12.37 $497,500 - $773,125
62,500 Added 4.59%
1,424,600 $15.1 Million
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $1.55 Million - $4.06 Million
315,800 Added 30.18%
1,362,100 $16.3 Million
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $964,600 - $1.55 Million
-137,800 Reduced 11.64%
1,046,300 $7.32 Million
Q2 2023

Aug 11, 2023

BUY
$7.61 - $9.46 $1.2 Million - $1.49 Million
157,200 Added 15.31%
1,184,100 $10.1 Million
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $716,996 - $1.43 Million
81,200 Added 8.59%
1,026,900 $9.39 Million
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $2.02 Million - $3.72 Million
185,300 Added 24.37%
945,700 $10.8 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $3.34 Million - $5.48 Million
-207,800 Reduced 21.46%
760,400 $12.9 Million
Q2 2022

Aug 12, 2022

BUY
$20.49 - $39.72 $13 Million - $25.3 Million
636,300 Added 191.71%
968,200 $20.8 Million
Q1 2022

May 13, 2022

BUY
$28.19 - $46.6 $6.8 Million - $11.2 Million
241,300 Added 266.34%
331,900 $12.3 Million
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $8.58 Million - $15.3 Million
-208,300 Reduced 69.69%
90,600 $4.12 Million
Q3 2021

Nov 12, 2021

BUY
$59.15 - $91.99 $17.7 Million - $27.5 Million
298,900 New
298,900 $18.9 Million
Q2 2021

Aug 13, 2021

SELL
$63.02 - $95.11 $743,636 - $1.12 Million
-11,800 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$57.62 - $95.6 $679,916 - $1.13 Million
11,800 New
11,800 $803,000
Q4 2020

Feb 10, 2021

SELL
$41.43 - $77.09 $7.06 Million - $13.1 Million
-170,400 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$30.88 - $37.94 $5.26 Million - $6.46 Million
170,400 New
170,400 $6.47 Million
Q4 2019

Feb 13, 2020

SELL
$19.24 - $28.41 $4.75 Million - $7.02 Million
-247,000 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$20.03 - $40.08 $1.72 Million - $3.44 Million
-85,800 Reduced 25.78%
247,000 $5.59 Million
Q2 2019

Aug 12, 2019

BUY
$25.78 - $39.77 $1.69 Million - $2.61 Million
65,600 Added 24.55%
332,800 $12 Million
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $2.73 Million - $4.85 Million
123,600 Added 86.07%
267,200 $8.42 Million
Q4 2018

Feb 13, 2019

BUY
$19.89 - $30.02 $2.86 Million - $4.31 Million
143,600 New
143,600 $3.61 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.24B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.